These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 22288597)
1. Induction of elastin expression in vascular endothelial cells relates to hepatoportal sclerosis in idiopathic portal hypertension: possible link to serum anti-endothelial cell antibodies. Sato Y; Ren XS; Harada K; Sasaki M; Morikawa H; Shiomi S; Honda M; Kaneko S; Nakanuma Y Clin Exp Immunol; 2012 Mar; 167(3):532-42. PubMed ID: 22288597 [TBL] [Abstract][Full Text] [Related]
2. Role of endothelial-mesenchymal transition in idiopathic portal hypertension. Sato Y; Nakanuma Y Histol Histopathol; 2013 Feb; 28(2):145-54. PubMed ID: 23275299 [TBL] [Abstract][Full Text] [Related]
4. POEMS syndrome and idiopathic portal hypertension: a possible association. Campos S; Agostinho C; Cipriano MA Rev Esp Enferm Dig; 2017 May; 109(5):393. PubMed ID: 28247771 [TBL] [Abstract][Full Text] [Related]
5. Endothelial to mesenchymal transition via transforming growth factor-beta1/Smad activation is associated with portal venous stenosis in idiopathic portal hypertension. Kitao A; Sato Y; Sawada-Kitamura S; Harada K; Sasaki M; Morikawa H; Shiomi S; Honda M; Matsui O; Nakanuma Y Am J Pathol; 2009 Aug; 175(2):616-26. PubMed ID: 19608867 [TBL] [Abstract][Full Text] [Related]
6. [Chronic arsenic poisoning and idiopathic portal hypertension: report of a case]. Wang Z; Jiang Y; Yang CQ; Liu DG Zhonghua Bing Li Xue Za Zhi; 2012 Jul; 41(7):487-8. PubMed ID: 22932465 [No Abstract] [Full Text] [Related]
7. Hepatoportal sclerosis related to the use of herbals and nutritional supplements. Causality or coincidence? Rios FF; Rodrigues de Freitas LA; Codes L; Santos Junior GO; Schinoni MI; Paraná R Ann Hepatol; 2016 Nov-Dec 2016; 15(6):932-938. PubMed ID: 27740529 [TBL] [Abstract][Full Text] [Related]
8. Idiopathic non cirrhotic portal hypertension and spleno-portal axis abnormalities in patients with severe primary antibody deficiencies. Pulvirenti F; Pentassuglio I; Milito C; Valente M; De Santis A; Conti V; d'Amati G; Riggio O; Quinti I J Immunol Res; 2014; 2014():672458. PubMed ID: 24741616 [TBL] [Abstract][Full Text] [Related]
9. Clinical features of idiopathic portal hypertension in China: A retrospective study of 338 patients and literature review. Sun Y; Lan X; Shao C; Wang T; Yang Z J Gastroenterol Hepatol; 2019 Aug; 34(8):1417-1423. PubMed ID: 30462857 [TBL] [Abstract][Full Text] [Related]
10. Portal and parenchymal alterations of the liver in idiopathic portal hypertension: a histological and immunochemical study. Tsuneyama K; Kouda W; Nakanuma Y Pathol Res Pract; 2002; 198(9):597-603. PubMed ID: 12440782 [TBL] [Abstract][Full Text] [Related]
12. Pathomorphologic study on the extrahepatic portal vein in idiopathic portal hypertension. Kage M; Arakawa M; Fukuda K; Kojiro M Liver; 1990 Aug; 10(4):209-16. PubMed ID: 2170796 [TBL] [Abstract][Full Text] [Related]
13. Idiopathic portal hypertension and its pathology. Okudaira M; Ohbu M; Okuda K Semin Liver Dis; 2002 Feb; 22(1):59-72. PubMed ID: 11928079 [TBL] [Abstract][Full Text] [Related]
14. Noninvasive diagnostic method for idiopathic portal hypertension based on measurements of liver and spleen stiffness by ARFI elastography. Furuichi Y; Moriyasu F; Taira J; Sugimoto K; Sano T; Ichimura S; Miyata Y; Imai Y J Gastroenterol; 2013 Sep; 48(9):1061-8. PubMed ID: 23142969 [TBL] [Abstract][Full Text] [Related]
15. Idiopathic portal hypertension associated with high serum titer of autoantibodies and liver dysfunction. Mori K; Ishimura E; Goto H; Shoji S; Seki S; Yamashita T; Wakasa K; Nishizawa Y; Morii H J Gastroenterol; 1996 Feb; 31(1):123-8. PubMed ID: 8808441 [TBL] [Abstract][Full Text] [Related]
16. Noncirrhotic Portal Hypertension: Current and Emerging Perspectives. Khanna R; Sarin SK Clin Liver Dis; 2019 Nov; 23(4):781-807. PubMed ID: 31563222 [TBL] [Abstract][Full Text] [Related]
17. Hepatoportal sclerosis in childhood: some presenting with cholestatic features (a re-evaluation of 12 children). Yilmaz G; Sari S; Egritas O; Dalgic B; Akyol G Pediatr Dev Pathol; 2012; 15(2):107-13. PubMed ID: 22150463 [TBL] [Abstract][Full Text] [Related]
18. A comparative histological and morphometric study of vascular changes in idiopathic portal hypertension and alcoholic fibrosis/cirrhosis. Tsuneyama K; Ohba K; Zen Y; Sato Y; Niwa H; Minato H; Nakanuma Y Histopathology; 2003 Jul; 43(1):55-61. PubMed ID: 12823713 [TBL] [Abstract][Full Text] [Related]
19. Immunoglobulin G anti-endothelial cell antibodies: inducers of endothelial cell apoptosis in pulmonary arterial hypertension? Arends SJ; Damoiseaux JG; Duijvestijn AM; Debrus-Palmans L; Vroomen M; Boomars KA; Brunner-La Rocca HP; Reutelingsperger CP; Cohen Tervaert JW; van Paassen P Clin Exp Immunol; 2013 Dec; 174(3):433-40. PubMed ID: 23815467 [TBL] [Abstract][Full Text] [Related]
20. The level of IgA antibodies to human umbilical vein endothelial cells can be enhanced by TNF-alpha treatment in children with Henoch-Schönlein purpura. Yang YH; Wang SJ; Chuang YH; Lin YT; Chiang BL Clin Exp Immunol; 2002 Nov; 130(2):352-7. PubMed ID: 12390327 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]